Home / Market News / $MNDY
benzinga Corporate Catalyst Impact 85/100 ● negative

US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results

Aug 10, 2026, 1:40 PM UTC · Primary ticker $MNDY

The filing primarily details Monday.Com's Q2 earnings, which beat estimates, but its weak Q3 sales guidance led to a significant stock drop. Broader market indices (Dow, NASDAQ, S&P 500) traded slightly lower, with energy as the leading sector and real estate lagging. Several other companies experienced extreme stock movements due to specific corporate news.

The filing highlights Monday.Com's Q2 performance, where strong earnings were overshadowed by disappointing Q3 sales guidance, causing a 10% stock decline. This is a significant corporate catalyst, as future guidance often dictates investor sentiment more than past performance. Other companies like Socket Mobile, Sionna Therapeutics, and Tenax Therapeutics experienced extreme volatility due to specific corporate news such as new agreements or failed clinical trials, indicating company-specific events are driving major price movements. While the broader market saw minor declines, the individual stock reactions underscore the importance of fundamental news for specific equities, creating both short-term trading opportunities and long-term risk for investors in these companies.

$MNDY negative Weak Q3 sales guidance
$SCKT positive Distribution agreement
$SION negative Failed clinical trial endpoint
$TENX negative Failed clinical trial endpoints
$AIRS negative Worse-than-expected Q2 sales and weak guidance
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.